Vicky Cameron

Q: What Schools Are Affiliated With Vicky Cameron

Vicky Cameron is affiliated with the following schools: University of Auckland, University of New Zealand

Vicky Cameron's AcademicInfluence.com Rankings

Vicky Cameron

Law

#3318

World Rank

#4179

Historical Rank

Common Law

#228

World Rank

#247

Historical Rank

law Degrees

Download Badge

Vicky Cameron's Degrees

Bachelors Biomedical Science University of Auckland
PhD Medical Research University of New Zealand

Why Is Vicky Cameron Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anne Victoria Cameron is a New Zealand medical researcher specialising in molecular endocrinology. Academic career Cameron was working as a scientific officer at the Christchurch School of Medicine, University of Otago, when she completed her PhD entitled The Role of Brain Hormones in the Regulation of Hypothalamic-Pituitary Secretion During Acute Haemorrhagic Stress in 1990. After a Fogarty Postdoctoral Research Fellowship-supported postdoc at the Salk Institute, in San Diego, she returned to Christchurch in 1993, rising to full professor.

(See a Problem?)

Vicky Cameron's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. (2007) (335)
Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. (1992) (262)
Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. (1994) (216)
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study (2018) (177)
Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (2015) (174)
Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients (2013) (159)
Minireview: natriuretic peptides during development of the fetal heart and circulation. (2003) (155)
The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. (1996) (131)
Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. (1993) (119)
Novel sites of adrenomedullin gene expression in mouse and rat tissues. (1998) (110)
Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. (2002) (99)
Integrated Hemodynamic, Hormonal, and Renal Actions of Urocortin 2 in Normal and Paced Sheep: Beneficial Effects in Heart Failure (2005) (92)
Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. (2000) (78)
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. (2005) (74)
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. (2013) (72)
Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. (2003) (70)
Amino-Terminal proCNP: A Putative Marker of Cartilage Activity in Postnatal Growth (2005) (69)
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. (2007) (69)
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction. (2008) (68)
Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy (2017) (66)
The hormonal actions of corticotropin-releasing factor in sheep: effect of intravenous and intracerebroventricular injection. (1983) (64)
Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. (2014) (62)
Vitamin C Status Correlates with Markers of Metabolic and Cognitive Health in 50-Year-Olds: Findings of the CHALICE Cohort Study (2017) (61)
Angiotensinogen M235T and T174M Gene Polymorphisms in Combination Doubles the Risk of Mortality in Heart Failure (2007) (59)
Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure (2006) (57)
Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage. (1985) (55)
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes. (2019) (54)
The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design. (2013) (54)
A Common Variant at Chromosome 9P21.3 Is Associated With Age of Onset of Coronary Disease but Not Subsequent Mortality (2010) (53)
Genomic selection of reference genes for real-time PCR in human myocardium (2008) (52)
Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure. (2006) (50)
Risk-taking: behind the warrior gene story. (2007) (50)
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. (2011) (48)
The Chromosome 9p21.3 Coronary Heart Disease Risk Allele Is Associated with Altered Gene Expression in Normal Heart and Vascular Tissues (2012) (47)
Genomic Risk Variants at 1p13.3, 1q41, and 3q22.3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Disease (2011) (46)
Adrenomedullin expression in rat uterus is correlated with plasma estradiol. (2002) (43)
B-Type Natriuretic Peptide Signal Peptide Circulates in Human Blood: Evaluation as a Potential Biomarker of Cardiac Ischemia (2010) (42)
Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells (2018) (41)
Adrenomedullin and heart failure (2003) (41)
Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes. (2014) (41)
Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. (1990) (40)
Genetic Polymorphism rs6922269 in the MTHFD1L Gene Is Associated with Survival and Baseline Active Vitamin B12 Levels in Post-Acute Coronary Syndromes Patients (2014) (40)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
Impact of age, phenotype and cardio‐renal function on plasma C‐type and B‐type natriuretic peptide forms in an adult population (2013) (39)
A cohort study comparing cardiovascular risk factors in rural Māori, urban Māori and non-Māori communities in New Zealand (2012) (36)
Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. (2006) (36)
Activation of NF-κB nuclear transcription factor by flow in human endothelial cells (2003) (34)
Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. (2009) (34)
Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction. (2000) (32)
Identifying Barriers to Smoking Cessation in Rheumatoid Arthritis (2015) (31)
A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study. (2014) (31)
Hyperuricaemia and gout in New Zealand rural and urban Māori and non‐Māori communities (2013) (31)
Hydrogen sulfide acts as a pro‐inflammatory mediator in rheumatic disease (2017) (31)
Hormone and hemodynamic responses to atrial natriuretic peptide in conscious sheep and effect of hemorrhage. (1988) (28)
A Kaupapa Māori approach to a community cohort study of heart disease in New Zealand (2011) (28)
Adriamycin disruption of the Shh-Gli pathway is associated with abnormalities of foregut development. (2004) (28)
Intra-cerebroventricular captopril reduces plasma ACTH and vasopressin responses to hemorrhagic stress. (1986) (28)
Efficacy of a Rheumatoid Arthritis–Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial (2016) (26)
Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. (2008) (25)
Impact of Selection Bias on Estimation of Subsequent Event Risk (2017) (23)
Genetic variation in the renin–angiotensin–aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease (2013) (23)
Canterbury Health, Ageing and Life Course (CHALICE) study: rationale, design and methodology. (2013) (22)
Activation of NF-kappaB nuclear transcription factor by flow in human endothelial cells. (2003) (22)
The characterization of ovine genes for atrial, brain, and C-type natriuretic peptides. (1999) (21)
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019) (21)
The New Zealand 1986 very low birth weight cohort as young adults: mapping the road ahead (2015) (21)
Living in areas with different levels of earthquake damage and association with risk of cardiovascular disease: a cohort-linkage study. (2017) (20)
Ile164 variant of β2‐adrenoceptor does not influence outcome in heart failure but may interact with β blocker treatment (2008) (20)
The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction (2009) (20)
Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment. (2008) (19)
Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. (2012) (19)
Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand. (2018) (18)
Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice. (2012) (18)
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. (2006) (18)
New Insights into Cardiac and Vascular Natriuretic Peptides: Findings from Young Adults Born with Very Low Birth Weight. (2018) (16)
Community screening for cardiovascular risk factors and levels of treatment in a rural Māori cohort (2011) (15)
Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019) (14)
Intracerebroventricular atrial natriuretic factor (ANF) antiserum inhibits volume-induced ANF in sheep: evidence for the brain's regulation of ANF secretion. (1991) (14)
Hydrogen Sulfide Treatment Improves Post-Infarct Remodeling and Long-Term Cardiac Function in CSE Knockout and Wild-Type Mice (2020) (14)
Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles. (2006) (13)
Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes (2018) (13)
KCNE5 Polymorphism rs697829 is Associated with QT Interval and Survival in Acute Coronary Syndromes Patients (2012) (13)
Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing. (2016) (13)
CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients (2010) (13)
Broken heart syndrome -- is it a psychosomatic disorder? (2014) (12)
Chronic Urocortin 2 Administration Improves Cardiac Function and Ameliorates Cardiac Remodeling After Experimental Myocardial Infarction (2015) (12)
C-Type Natriuretic Peptide Expression in Olfactory Regions of Rat Brain Is Modulated by Acute Water Deprivation, Salt Loading and Central Angiotensin II (2001) (12)
Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association. (2021) (11)
Developing a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients. (2016) (11)
Association of Genetic Variation in the Natriuretic Peptide System with Cardiovascular Outcomes (2010) (11)
Metabolic and Blood Pressure Effects of Walnut Supplementation in a Mouse Model of the Metabolic Syndrome (2017) (11)
Hemodynamic and Hormonal Effects of Neutral Endopeptidase Inhibitor SCH 39370 in Sheep (1991) (11)
Copy number variants implicate cardiac function and development pathways in earthquake-induced stress cardiomyopathy (2017) (10)
Genetic markers of repolarization and arrhythmic events after acute coronary syndromes. (2015) (10)
Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease (2021) (10)
Biological Actions of Cleaved Atrial Natriuretic Factor (ANF101–105/106–126) in Conscious Sheep (1991) (9)
Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart disease (2019) (9)
Association of Factor V Leiden With Subsequent Atherothrombotic Events (2020) (8)
The development of guidelines for handling samples and specimens collected for research involving Maori. (2007) (8)
Improving Cardiovascular Risk Prediction in the General Population (2015) (8)
Absence of a NPR-A gene functional deletion allele in a postmyocardial infarction cohort from New Zealand. (2004) (8)
Exploring perceptions of a rheumatoid arthritis‐specific smoking cessation programme (2017) (7)
Intracerebroventricular atrial natriuretic peptide infusion augments the adrenocorticotropin and angiotensin II responses to hemorrhage in sheep. (1990) (7)
Higher prevalence of left ventricular hypertrophy in two Māori cohorts: findings from the Hauora Manawa/Community Heart Study (2015) (6)
Effect of central naloxone on hormone and blood pressure responses to hemorrhage in conscious sheep. (1987) (5)
Impact of COVID-19 on health research in New Zealand: a case study of a research-intensive campus (2021) (5)
Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals (2021) (4)
Twelve Lead Electrocardiographic Findings Among Māori and non-Māori at Risk of Cardiovascular Disease in NZ (2013) (4)
Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma (2022) (4)
Evidence for activation of brain atrial natriuretic factor during acute plasma volume expansion in sheep. (1990) (3)
Novel and Annotated Long Noncoding RNAs Associated with Ischemia in the Human Heart (2021) (3)
Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes (2021) (3)
Association of the aldosterone synthase gene C-344T polymorphism with risk factors and survival in a post-myocardial infarction cohort (2007) (3)
Effect of metoclopramide on adrenal secretion in sheep: influence of dexamethasone and sodium intake. (1987) (3)
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations (2022) (2)
The common G-866 A polymorphism of the UCP 2 gene and survival in diabetic patients following myocardial infarction (2015) (2)
Adjusting protocols in clinical research: finding the point of cultural/clinical fusion. (2011) (2)
The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and Methodology (2021) (2)
Abstract 18066: Elevated Levels of Circulating MicroRNA-223, MicroRNA-127 and MicroRNA-146a are Associated with Risk of Near Future Cardiovascular Events in Asymptomatic Individuals (2014) (2)
Circulating MicroRNAs as Biomarkers in Coronary Heart Disease and Heart Failure (2014) (2)
Screening for Cardiovascular Disease in Maori Communities: The Community Heart Study (2009) (1)
Chronic Urocortin 2 Treatment Significantly Improves Cardiovascular Function and Attenuates Cardiac Injury and Remodelling after Experimental Myocardial Infarction (2010) (1)
Abstract 1812: The Chromosome 9p21.3 Coronary Artery Disease Risk Locus is Associated with Altered Cardiac Gene Expression in Individuals without Overt Cardiac Abnormality (2008) (1)
Hydrogen Sulfide and Substance P Levels in Patients with Escherichia coli and Klebsiella pneumoniae Bacteraemia (2022) (1)
Natriuretic peptide system in fetal heart and circulation. (2002) (1)
Loose tobacco, ethnicity, income and rurality (2012) (1)
Letter to the editorAngiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply (2003) (1)
Emerging microRNA biomarkers for acute kidney injury in acute decompensated heart failure (2020) (1)
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples (2022) (1)
AMPD1 gene polymorphism and survival in patients with stable congestive heart failure. (2007) (1)
Acute hemorrhage reduces angiotensin converting enzyme activity in conscious sheep. (1987) (1)
Abstract 16095: Plasma NT-proBNP Concentrations are Two-fold Lower in Pacific versus European Population Samples: Evidence for Glycosylation Impacting Assay Detection and/or ProBNP Processing (2020) (1)
Diabetes causes the activation of the pro-ageing miRNA-34a in the human heart (2014) (0)
Subject Index Vol. 52, 1990 (1990) (0)
Ethnic-Specific Cardiovascular Disease Risk Prediction Scores (2019) (0)
1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title : (2019) (0)
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis (2022) (0)
EARLY POST TRANSPLANT ANAEMIA IS NOT ASSOCIATED WITH THE ANGIOTENSIN II TYPE 1 A1166C SINGLE NUCLEOTIDE POLYMORPHISM OR ANGIOTENSIN CONVERTING ENZYME INSERTIN/DELETION POLYMORPHISM IN RENAL TRANSPLANTATION: 2247 (2008) (0)
Donor and Recipient Angiotensin II Type 1 Receptor Polymorphisms and Haplotypes and Allograft Outcome in Renal Transplantation.: Abstract# A519 (2014) (0)
960Dietary intakes of patients with first Acute Coronary Syndrome: the MENZACS study (2021) (0)
Risk of sudden cardiac death following acute coronary syndromes: Interplay of single nucleotide polymorphisms and the presence of heart failure (2014) (0)
Apolipoprotein E isoforms are associated with age of onset of coronary disease but not subsequent mortality in a coronary disease cohort (2010) (0)
Pharmacogenomics of antidepressant drug responses (2002) (0)
P4761Genetic risk variants for heart failure onset and progression do not improve prediction of mortality beyond established prognostic neurohormonal and echocardiographic markers (2018) (0)
Characterising a novel mouse model of the metabolic syndrome (2009) (0)
Metabolic Syndrome Alters Expression Levels of Metabolic Disease Risk Loci Genes (2010) (0)
Abstract 19648: Amino-Terminal Pro-Brain Natriuretic Peptide Improves Risk Stratification in Asymptomatic Individuals at Very High Risk of Future Cardiovascular Events (2014) (0)
Acute Myocardial Infarction Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction (2016) (0)
Abstract 12170: Chromosome 1q41 and 3q22.3 Coronary Artery Disease Risk Loci are Associated with Altered Cardiac Gene Expression Profiles in Normal and Diseased Heart (2011) (0)
Outcomes Among Patients With First-Time Acute Coronary Syndromes in New Zealand: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS) (2021) (0)
A028 The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Baseline Characteristics of Patients With First-time ACS (2020) (0)
Copy number variants implicate cardiac function and development pathways in earthquake-induced stress cardiomyopathy (2018) (0)
126 CHROMOSOME 9P21 LOCUS AND ANGIOGRAPHIC CORONARY ARTERY DISEASE BURDEN: A COLLABORATIVE META-ANALYSIS (2013) (0)
Abstract 19750: Cardiac Biomarkers and MicroRNAs as Predictors of Cardiovascular Events in Asymptomatic Individuals (2017) (0)
Abstract 290: Circulating miRNAs as Biomarkers in Acute Coronary Syndrome (2012) (0)
S4-2 Gene Polymorphisms in Patients with Heart Failure and Acute Coronary Syndromes (2009) (0)
Abstract 1882: Chromosome 6q25.1 and 2q36.3 Coronary Heart Disease Risk Loci Are Associated With Altered Cardiac Gene Expression Profiles in Normal Heart (2009) (0)
Abstract 20232: Circulating MicroRNAs Associated With Cardiovascular Disease Do Not Improve Prediction of Incident Cardiovascular Events Within Five Years in Asymptomatic Individuals (2016) (0)
Harnessing the Power of “Omics”: Discovering Novel microRNA and Protein Biomarkers of Acute Kidney Injury in Acute Heart Failure (2022) (0)
Factors Affecting Blood Sampling in Acute Coronary Syndromes: Relationship to Patient and Logistic Factors—A MENZACS Substudy (2019) (0)
Comparison of SPEED, S-Trap, and In-Solution-Based Sample Preparation Methods for Mass Spectrometry in Kidney Tissue and Plasma (2023) (0)
Clinical Trial: Methods and Design The Singapore Heart Failure Outcomes and Phenotypes (SHOP) Study and Prospective Evaluation of Outcome in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PEOPLE) Study: Rationale and Design (2013) (0)
sFlt-1 and NTproBNP independently predict mortality in a cohort of heart failure patients. (2018) (0)
A Comparison of Metabolic Risk Profiles Among Rural and Urban Māori in New Zealand (2010) (0)
Abstract 11775: Change in Circulating Mir-652 Predicts Mortality in Patients with Acute Coronary Syndromes (2012) (0)
Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New Zealand (2023) (0)
Higher Allelic Frequency of Variants at the 9p21 Locus in Maori and Pacific Islanders Presenting With Severe Coronary Artery Disease (2009) (0)
Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure (2022) (0)
Myocardial expression of Corticotropin-Releasing Factor Receptor 1 (CRFR1) is elevated in human heart failure and is modulated by genetic variation and a novel CRFR1 splice variant. (2016) (0)
Abstract 13115: Circulating MicroRNA-454-3p is Associated With Acute Kidney Injury in Patients With Acute Decompensated Heart Failure (2019) (0)
Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells (2018) (0)
DNA methylation patterns at birth predict health outcomes in young adults born very low birthweight (2023) (0)

This paper list is powered by the following services:

Other Resources About Vicky Cameron

en.wikipedia.org

What Schools Are Affiliated With Vicky Cameron?

Vicky Cameron is affiliated with the following schools:

Vicky Cameron's Academic­Influence.com Rankings